ZYDUS WELLNESS LTD.-$ - 531335 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate / issue of duplicate share certificate under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations)
Buy Zydus Wellness; target of Rs 2100: ICICI Direct
ICICI Direct is bullish on Zydus Wellness recommended buy rating on the stock with a target price of Rs 2100 in its research report dated November 11, 2022. Zydus Lifesciences gets exclusive marketing rights for CanAssist Breast
The prognostic test for breast cancer brings in 95% precision in gauging whether patients need chemotherapy or not
Buy Zydus Wellness; target of Rs 1975: Sharekhan
Sharekhan is bullish on Zydus Wellness has recommended buy rating on the stock with a target price of Rs 1975 in its research report dated November 10, 2022. ZYDUS WELLNESS LTD.-$ - 531335 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate / issue of duplicate share certificate under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations) ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of the Company's Q2 FY23 post results Investors' call held on November 10, 2022
Zydus Lifesciences Q2 net profit falls to Rs 522.5 crore
Sharvil Patel, Managing Director, Zydus Lifesciences Limited, said: "Our Q2 FY23 performance reflects strong execution in our key businesses, sustaining growth momentum and profitability."
Results Earnings Call for Q2FY23 of Zydus Wellness
Conference Call with Zydus Wellness Management and Analysts on Q2FY23 Performance and Outlook. Listen to the full earnings transcript. ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper cutting dated November 11, 2022 with regard to unaudited financial results of the Company for the quarter and half year ended on September 30, 2022 published in the Financial Express English and Gujarati Editions ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of the Investor Call on unaudited financial results for the quarter and half year ended on September 30, 2022